Vivesto AB

Stocks

Market Closed - Nasdaq Stockholm 19:00:00 29/09/2026 +03			5-day change	1st Jan Change
8.510 ^SEK	-1.96%		-4.27%	-36.96%

09-24	Vivesto to present Paccal Vet data at conference	FW
09-24	Vivesto AB Presents Paccal Vet Data At The Veterinary Cancer Society Annual Conference 2026	CI

Published on 11/24/2025 at 07:35 pm +03 - Modified on 11/25/2025 at 01:40 am +03

S&P Capital IQ

Presenter Speech
Mikael Magnusson (Attendees)

The clock strikes 3:00 p.m., and we welcome viewers here to Vivesto's business update. Today, we will hear about the company with a focus towards the

This article is reserved for our subscribers.

Subcribe
to read the article

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

09-24	Vivesto to present Paccal Vet data at conference	FW
09-24	Vivesto AB Presents Paccal Vet Data At The Veterinary Cancer Society Annual Conference 2026	CI
09-17	Vivesto sees tumor effect with Paccal Vet in cat study	FW
09-17	Vivesto reports positive topline results from the Paccal Vet feline study	FW
09-17	Vivesto Reports Positive Paccal Vet Cat Topline Results Supporting Continued Clinical Development	CI
09-15	Vivesto reports positive topline results in pilot dog study (update)	FW
09-15	Vivesto reports positive topline results in pilot dog study	FW
09-15	Vivesto AB Reports Positive Topline Results from Clinical Pilot Study Evaluating Paccal Vet in Dogs with Splenic Hemangiosarcoma Following Splenectomy	CI
08-13	Vivesto narrowed its loss in the second quarter, CEO says: we are staying on plan	FW
08-13	Vivesto AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-13	Calendar for Thursday, August 13	FW
07-07	Vivesto chairman Peter Zonabend increases his shareholding	FW
07-01	Vivesto Completes Enrollment in Cat Study of Paccal Vet	FW
07-01	Vivesto Completes Recruitment in Paccal Vet Dose-Finding Study in Cats and Determines Maximum Tolerated Dose	CI
06-26	Vivesto Completes Enrollment in Canine Study	FW

Duration

Period

Sector